Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
25 hedge funds and large institutions have $6.49M invested in Fibrocell Science Inc. in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 9 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
4% more capital invested
Capital invested by funds: $6.24M → $6.49M (+$253K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 30 → 25 (-5)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$402K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$339K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$143K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$43.4K |
| 5 |
KFA
Kabarec Financial Advisors
Palatine,
Illinois
|
+$31.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
-$21K |
| 2 |
Bank of New York Mellon
New York
|
-$19K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$19K |
| 4 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
-$18K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SKK
26
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$17K | -5,600 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$16K | -5,299 | Closed |
|
|
FSA
28
Franklin Street Advisors
Chapel Hill,
North Carolina
| – | -$10K | -3,333 | Closed |
|
29
Bank of America
Charlotte,
North Carolina
| – | -$35 | -12 | -86% |
|
|
AG
30
Advisor Group
Phoenix,
Arizona
| – | +$3 | +1 | +2% |
|
|
IA
31
IFP Advisors
Tampa,
Florida
| – | +$3 | +1 | +8% |
|
FCSC Hedge Fund Activity: Q2 2018 in Review
25 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q2 2018, worth a combined $6.49M — up 4.1% from $6.24M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of FCSC and 5 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 11 added.
The largest buyer was Renaissance Technologies, adding an estimated $402K. The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $21K sold.
- 25 institutional investors held Fibrocell Science Inc. (FCSC) as of Q2 2018, down from 30 in Q1 2018.
- Funds reported $6.49M of Fibrocell Science Inc. stock for Q2 2018, up 4.1% quarter-over-quarter.
- 5 funds opened new Fibrocell Science Inc. positions in Q2 2018 and 9 closed out, a net change of -4 holders.
- The largest Fibrocell Science Inc. buyer in Q2 2018 was Renaissance Technologies, an estimated $402K added.
- The largest Fibrocell Science Inc. seller in Q2 2018 was California Public Employees Retirement System, an estimated $21K sold.
Based on aggregated 13F filings for Q2 2018.